Is APOE useful for blood sugar?

APOE variants (ε2, ε3, ε4) are primarily studied for their role in lipid metabolism and Alzheimer's disease risk. Their utility for blood sugar management is limited. Some observational studies have reported modest associations between APOE ε4 and higher fasting glucose or insulin resistance, but findings are inconsistent and effect sizes are small. No clinical guidelines recommend APOE genotyping for glycemic control. For actionable insights into blood sugar regulation, direct biomarkers (HbA1c, fasting glucose, OGTT) and lifestyle factors (diet, exercise) are far more relevant. APOE may be part of a broader cardiovascular risk assessment, but it is not a useful standalone test for blood sugar. Evidence: human-moderate (associations exist but lack clinical utility for this specific question).